- Open Access
Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy
- Min Gu†1,
- Wujie Liu†1,
- Lijun Xu1,
- Yongzhong Cao1,
- Chunfeng Yao1,
- Shunlin Hu1 and
- Xiufan Liu1Email author
© Gu et al; licensee BioMed Central Ltd. 2011
- Received: 16 November 2010
- Accepted: 31 March 2011
- Published: 31 March 2011
To investigate the relationship between the selective pressure and the sequence variation of the hemagglutinin-neuraminidase (HN) protein, we performed the positive selection analysis by estimating the ratio of non-synonymous to synonymous substitutions with 132 complete HN gene sequences of Newcastle disease viruses (NDVs) isolated in China.
The PAML software applying a maximum likelihood method was used for the analysis and three sites (residues 266, 347 and 540) in the HN protein were identified as being under positive selection. Codon 347 was located exactly in a recognized antigenic determinant (residues 345-353) and codon 266 in a predicted linear B-cell epitope. Substitutions at codon 540 contributed to the N-linked glycosylation potential of residue 538. To further evaluate the effect of positively selected sites on the vaccine efficacy, we constructed two recombinant fowlpox viruses rFPV-JS6HN and rFPV-LaSHN, expressing the HN proteins from a genotype VII field isolate Go/JS6/05 (with A266, K347 and A540) and vaccine strain La Sota (with V266, E347 and T540), respectively. Two groups of SPF chickens, 18 each, were vaccinated with the two recombinant fowlpox viruses and challenged by Go/JS6/05 at 3 weeks post-immunization. The results showed that rFPV-JS6HN could elicit more effective immunity against the prevalent virus infection than rFPV-LaSHN in terms of reducing virus shedding.
The analysis of positively selected codons and their effect on the vaccine efficacy indicated that the selective pressure on the HN protein can induce antigenic variation, and new vaccine to control the current ND epidemics should be developed.
- Newcastle Disease Virus
- Vaccine Strain
- Newcastle Disease
- Newcastle Disease Virus Strain
- Rabbit Hemorrhagic Disease Virus
Newcastle disease (ND) is notorious for its devastations to the world poultry industry and listed as one of the notifiable terrestrial animal diseases by the World Organization for Animal Health (Office International des Epizooties). The causative agent, Newcastle disease virus (NDV), also known as avian paramyxovirus serotype 1, is a member of the family Paramyxoviridae . The virus genome is a non-segmented, single-strand, negative sense RNA which codes for six major proteins including nucleocapsid protein (NP), phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin-neuraminidase (HN), and large RNA-directed RNA polymerase (L), in the order from the 3' to 5' terminus . Since its emergence in fowls in 1926, NDV has undergone substantial genetic evolution and has developed into several distinct genotypes (I to IX) [3, 4]. Among these, genotype VII is considered to be responsible for the severe outbreaks in Western Europe , South Africa and Southern Europe , and East Asia [6, 7] in the 1990s. Presently, the genotype VII NDV is still prevalent in China [4, 8–10].
Although the cleavability of F protein is pivotal to NDV pathogenicity [11, 12], recent studies have shown that HN protein also contributes to tissue tropism and virulence . HN is an important immunoprotective glycoprotein on the envelope of ND virions and responsible for essential viral functions, such as binding to sialic acid-containing cell receptors, facilitating the fusion activity of the F protein and removing sialic acid to release progeny virus particles . Despite the critical role that HN protein plays in NDV immunity and pathogenesis, the positive selection pressure acting on HN during the viral evolution has not been well analyzed.
The ratio of non-synonymous (d N ) to synonymous (d S ) substitutions (ω = dN/dS) provides an important means for studying the selective pressure at the protein level, with ω = 1 denoting neutral mutations, ω < 1 purifying selection, and ω > 1 diversifying positive selection. As a high proportion of amino acids in many proteins is often largely invariable (with ω close to 0) due to strong structural and functional constraints, approaches conferring an average ω over all codons across the gene are not sensitive enough to detect positive selection . The program PAML [16, 17], which applies a maximum likelihood (ML) criterion and a few simple models allowing for heterogeneous ω ratios among sites, has been considered an efficient integrated method to estimate positive selection and has been commonly used to study virus evolution [18–21]. In this paper, the selective pressure on NDV HN protein was examined using 132 complete HN sequences (Chinese isolates), including 106 retrieved from GenBank (up to 14 April, 2009) and the other 26 obtained from field isolates. Based on the analysis, three codons of HN were identified under positive selection and their potential effect on the routine vaccine efficacy was then evaluated.
Four pigeon isolates: NDV03-018, NDV03-044, NDV05-028 and NDV05-029 , were kindly provided by Dr. Zhiliang Wang (China Animal Health and Epidemiology Center). Two chicken isolates, QH-1/79 and QH-4/85 , were obtained from Dr. Dianjun Cao (Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences). Twenty field strains were isolated from diseased chicken and goose flocks in China during 2005-2006. All of these viruses were subjected to three rounds of plaque-purification in chick embryo fibroblast (CEF) monolayers and subsequently propagated in 10-day-old specific pathogen free (SPF) chicken embryos. Infective allantoic fluid containing virus stocks was aliquoted and stored at -80°C before use.
RNA preparation, PCR, and sequencing
Viral RNAs were extracted directly from the allantoic fluid with the Trizol LS reagent (Invitrogen, Carlsbad, CA), following the manufacturer's instructions. Reverse transcription (RT) was conducted with random primers, and PCR was performed with a pair of primers (sense: 5'-CTTCACAACATCCGTTCTACC-3', antisense: 5'-ACCTTCCGAGTTTTATCATTCT-3') to amplify the full-length HN gene of NDV. The PCR products were purified with a DNA purification kit (QIAGEN, Hilden, Germany) and sequenced directly using the ABI PRISM BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA).
Sequence information and phylogenetic analysis
Accession numbers of the 106 complete HN gene sequences of NDVs isolated in China that were directly retrieved from GenBank (* sequences with lysine (K) at residue 347)
Positive selection detection
To estimate the selective constraints on the HN protein, the codeml program of the PAML package (version 4)  was utilized to calculate the site-to-site variation in ω. Two nested site-specific models, consisting of a neutral model that does not allow positive selection (ω≤1) and an alternative model that permits positive selection (ω > 1), were compared. As recommended , the following models were used: M0 (one-ratio) v. M3 (discrete) and M7 (beta) v. M8 (beta & ω). M0 assumes a constant ω for all codons whereas M3 allows for discrete classes of sites with different ω ratios. M7 supposes a beta distribution with 10 categories of ω over sites, each corresponding to a unique ω value that is always less than 1 while M8 has an extra category with ω > 1. Then the log likelihood values for each pair of the above nested models were compared by a likelihood ratio test (LRT) [15, 17], in order to assess whether the model allowing for positive selection is significantly more suitable for the data. Finally, the Bayes empirical Bayes (BEB) procedure  was used to infer the particular codons under positive selection and to calculate their posterior probabilities.
To further investigate the effect of positively selected sites on vaccine efficacy against the prevalent NDVs, Go/JS6/05 (field NDV strain) and La Sota (the most widely used vaccine strain in China) were chosen to construct corresponding recombinant fowlpox viruses (rFPVs) expressing each HN gene based on the transfer vector pP12LS developed by Sun et al . The expression was identified by indirect immunofluorescence assay (IFA) in secondary CEF cultures using anti-NDV polyclonal antibody as previously described , and the levels of HN expression were further compared between the two generated rFPVs by flow cytometry  on DF-1 cells (a stable cell line of CEF) at a multiplicity of infection (MOI) of 5. Subsequently, two groups of five-day-old SPF White Leghorn chickens (18 birds/group, Beijing Merial Vital Laboratory Animal Technology, Beijing, China) were immunized respectively with the above two rFPVs at a dose of 1 × 104 PFU. A third group was served as a mock-vaccinated control. Three weeks later, all chickens were challenged oculonasally with 100 μL of PBS-diluted allantoic fluid containing 1 × 105 EID50 of Go/JS6/05. Tracheal and cloacal swabs were collected on days 3, 5 and 7 post-challenge (p.c.). Furthermore, six chickens from each vaccinated group were sacrificed humanely on day 5 p.c., and tissue samples including liver, brain, spleen, kidney, trachea and lung were collected. The swabs were immersed in PBS with antibiotics (8000 U/mL ampicilin, 5 mg/mL streptomycin and kanamycin, pH 7.2), and stored at -80°C until analyzed. The recovery of the challenged virus in these swabs or organ samples was confirmed by inoculation into embryonated chicken eggs. All animal work was approved by the Jiangsu Administrative Committee for Laboratory Animals (Permission number: SYXK-SU-2007-0005).
Detection of positive selection
Parameter estimates and likelihood values corresponding to the results from different models
Positively selected codonsc
ω = 0. 225
p0= 0.656, p1= 0.310, p2= 0.034
ω0= 0.069, ω1= 0.446, ω2 = 1.313 d
276.552 (p < 0.01)
266, 347, 540
p = 0.486, q = 1.635
M8 (beta& ω)
p0= 0.968, p1= 0.032
p = 0.662, q = 2.730, ω = 1.312
13.740 (p < 0.01)
266, 347, 540
Amino acid variations of positively selected codons
Amino acid variations of the positively selected codons identified by M8
site ω( ± S.E.)c
1. 477 ± 0. 125
1. 485 ± 0. 100
1. 438 ± 0. 202
Generation of rFPVs expressing HN genes
Protective efficacies of rFPV-JS6HN and rFPV-LaSHN
HI titers to NDV at day pre-challenge and virus detection in visceral organs from different rFPV immunized groups on day 5 p.c.
HI titer ± standard deviationa
Virus detection (positive/total)c
3.80 ± 0.92 b
3.30 ± 1.16
1.50 ± 0.85
3.90 ± 0.57
Virus recovery of swab samples from different rFPV immunized groups challenged with NDV Go/JS6/05
No. of birds shedding/total no. of birds on day after challenge:
Positive selection is an evolutionary process that could drive the fixation of emerging advantageous mutations in the population with higher frequencies compared to the wild-type allele . Therefore, identifying proteins or protein domains that experiencing adaptive selection will improve the understanding of their genomic functions and the recognition of genetic variation that leads to phenotypic diversity .
Observations from previous genetic and antigenic studies of viruses such as FMDV (foot-and-mouth disease virus) , HIV-1 (human immunodeficiency virus type 1) , RHDV (rabbit hemorrhagic disease virus)  and influenza B virus , have indicated that signatures of positive selection are generally functionally important and/or associated with antigenicity. To date, seven antigenic determinants that form a continuum on HN protein have been characterized by a panel of monoclonal antibodies (mAbs) against the HN of the velogenic Australia-Victoria/32 (AV) strain, including the amino acids positions 193, 194, 201, 263, 287, 321, 332, 333, 345, 347, 350, 353, 356, 494, 513, 514, 516, 521 and 569 [36, 37]. One of our positively selected sites, codon 347, was located exactly in those defined epitopes. In the present study, both La Sota and Mukteswar, which are widely used vaccine strains in China, have a glutamic acid (E) occupied codon 347, in contrast to that with a lysine (K) substitution resulting in the opposite residual charge exclusively in genotype VII viruses (accession numbers in italic in Table 1). Furthermore, as referred to recent work of Cho et al  and Hu et al (2009) , it is reasonable to postulate that the emergence of E347K substitution might be closely related to the host immune pressure. However, the codon 266 was not included in the aforementioned antigenic sites [36, 37], instead, it was involved in a predicted linear B-cell epitope that simultaneously held the epitope residue 263, suggesting that site 266 may lie in some antigenic regions yet to be recognized.
N-linked glycosylation, one of the most common forms of protein post-translational modifications, is known to be correlated with viral infectivity and immune escape . There are six potential N-glycosylation sites (amino acids 119, 341, 433, 481, 508 and 538) in the HN protein of the AV strain . In our analysis, positive selection was detected at codon 540, which comprised three different amino acids: alanine (A), valine (V) and threonine (T). Residue 538 was conserved with asparagine (N) in all the 132 HN sequences and tended to be a putative N-glycosylation site if T was present at site 540. However, the vast majority of prevalent strains owned A or V at codon 540 (Additional file 1, Table S1), which would deprive the possibility of N538 being glycosylated. The exact function of the resulted deglycosylation at site 540 remains unknown and needs to be further explored.
Compared to vaccine strain La Sota, most genotype VII NDV isolates possessed different amino acids at the three identified positively selected sites. To further evaluate the effect of those sites on the vaccine protective efficacy, Go/JS6/05 was chosen together with La Sota for the recombinant fowlpox-virus construction. Before challenge, serum collected from the rFPV-LaSHN immunized chickens displayed lower HI titers to Go/JS6/05 than to La Sota (Table 4), which may suggest that substitutions at the positively selected sites are partially responsible for the antigenic variation between the two HN proteins. After challenge, virus shedding results showed that the rFPV-JS6HN could prevent the excretion of the challenged virus more efficiently than rFPV-LaSHN, indicating that the positively selected sites on the HN protein could affect the vaccine immune efficacy against the prevalent NDV infection.
Although an intensive vaccination program against ND has been executed in China in the last few decades, epidemic infections with velogenic genotype VII NDV in vaccinated birds are still frequently reported in recent years [4, 8–10]. Currently, the most extensively used vaccine strains, such as La Sota (genotype II) and Mukteswar (genotype III), were isolated and characterized in the 1940s and belonged to the "early" genotypes (I-IV and IX), which have evident amino acid sequence divergence from the "late" ones (V-VII), especially genotype VII . The results in this study suggest that positive selection may play a role in the formation of such differentiation and even induce antigenic variations compared with the vaccine strains. Therefore, new vaccine to better control the ND epizootics of prevalent NDV strains carrying novel variations at identified positively selected sites should be developed to meet the challenge.
This work was supported by National Natural Science Foundation of China (grant numbers: 30630048 and 30800814) and China Layer Industry Improvement program (grant number: nycytx-41-g07).
- Alexander DJ: Newcastle disease and other avian paramyxoviruses. Rev Sci Tech 2000, 19: 443-462.PubMedGoogle Scholar
- Kattenbelt JA, Stevens MP, Gould AR: Sequence variation in the Newcastle disease virus genome. Virus Res 2006, 116: 168-184. 10.1016/j.virusres.2005.10.001View ArticlePubMedGoogle Scholar
- Herczeg J, Wehmann E, Bragg RR, Travassos Dias PM, Hadjiev G, Werner O, Lomniczi B: Two novel genetic groups (VIIb and VIII) responsible for recent Newcastle disease outbreaks in Southern Africa, one (VIIb) of which reached Southern Europe. Arch Virol 1999, 144: 2087-2099. 10.1007/s007050050624View ArticlePubMedGoogle Scholar
- Liu XF, Wan HQ, Ni XX, Wu YT, Liu WB: Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001. Arch Virol 2003, 148: 1387-1403.PubMedGoogle Scholar
- Lomniczi B, Wehmann E, Herczeg J, Ballagi-Pordany A, Kaleta EF, Werner O, Meulemans G, Jorgensen PH, Mante AP, Gielkens AL, et al.: Newcastle disease outbreaks in recent years in western Europe were caused by an old (VI) and a novel genotype (VII). Arch Virol 1998, 143: 49-64. 10.1007/s007050050267View ArticlePubMedGoogle Scholar
- Yu L, Wang Z, Jiang Y, Chang L, Kwang J: Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol 2001, 39: 3512-3519. 10.1128/JCM.39.10.3512-3519.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Mase M, Imai K, Sanada Y, Sanada N, Yuasa N, Imada T, Tsukamoto K, Yamaguchi S: Phylogenetic analysis of Newcastle disease virus genotypes isolated in Japan. J Clin Microbiol 2002, 40: 3826-3830. 10.1128/JCM.40.10.3826-3830.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Qin ZM, Tan LT, Xu HY, Ma BC, Wang YL, Yuan XY, Liu WJ: Pathotypical characterization and molecular epidemiology of Newcastle disease virus isolates from different hosts in China from 1996 to 2005. J Clin Microbiol 2008, 46: 601-611. 10.1128/JCM.01356-07PubMed CentralView ArticlePubMedGoogle Scholar
- Liu H, Wang Z, Wu Y, Wu Y, Sun C, Zheng D, Xu T, Li J: Molecular characterization and phylogenetic analysis of new Newcastle disease virus isolates from the mainland of China. Res Vet Sci 2008, 85: 612-616. 10.1016/j.rvsc.2008.02.013View ArticlePubMedGoogle Scholar
- Liu H, Wang Z, Wu Y, Zheng D, Sun C, Bi D, Zuo Y, Xu T: Molecular epidemiological analysis of Newcastle disease virus isolated in China in 2005. J Virol Methods 2007, 140: 206-211. 10.1016/j.jviromet.2006.10.012View ArticlePubMedGoogle Scholar
- Panda A, Huang Z, Elankumaran S, Rockemann DD, Samal SK: Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog 2004, 36: 1-10. 10.1016/j.micpath.2003.07.003View ArticlePubMedGoogle Scholar
- Peeters BP, de Leeuw OS, Koch G, Gielkens AL: Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 1999, 73: 5001-5009.PubMed CentralPubMedGoogle Scholar
- Huang Z, Panda A, Elankumaran S, Govindarajan D, Rockemann DD, Samal SK: The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol 2004, 78: 4176-4184. 10.1128/JVI.78.8.4176-4184.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Scheid A, Choppin PW: Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol 1973, 11: 263-271.PubMed CentralPubMedGoogle Scholar
- Yang Z, Nielsen R, Goldman N, Pedersen AM: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 2000, 155: 431-449.PubMed CentralPubMedGoogle Scholar
- Yang Z: PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 2007, 24: 1586-1591. 10.1093/molbev/msm088View ArticlePubMedGoogle Scholar
- Nielsen R, Yang Z: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 1998, 148: 929-936.PubMed CentralPubMedGoogle Scholar
- Haydon DT, Bastos AD, Knowles NJ, Samuel AR: Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates. Genetics 2001, 157: 7-15.PubMed CentralPubMedGoogle Scholar
- Travers SA, O'Connell MJ, McCormack GP, McInerney JO: Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes. J Virol 2005, 79: 1836-1841. 10.1128/JVI.79.3.1836-1841.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Esteves PJ, Abrantes J, Carneiro M, Muller A, Thompson G, van der Loo W: Detection of positive selection in the major capsid protein VP60 of the rabbit haemorrhagic disease virus (RHDV). Virus Res 2008, 137: 253-256. 10.1016/j.virusres.2008.07.025View ArticlePubMedGoogle Scholar
- Shen J, Kirk BD, Ma J, Wang Q: Diversifying selective pressure on influenza B virus hemagglutinin. J Med Virol 2009, 81: 114-124. 10.1002/jmv.21335PubMed CentralView ArticlePubMedGoogle Scholar
- Liu H, Wang Z, Son C, Wang Y, Yu B, Zheng D, Sun C, Wu Y: Characterization of pigeon-origin Newcastle disease virus isolated in China. Avian Dis 2006, 50: 636-640. 10.1637/7618-042606R1.1View ArticlePubMedGoogle Scholar
- Liang R, Cao DJ, Li JQ, Chen J, Guo X, Zhuang FF, Duan MX: Newcastle disease outbreaks in western China were caused by the genotypes VIIa and VIII. Vet Microbiol 2002, 87: 193-203. 10.1016/S0378-1135(02)00050-0View ArticlePubMedGoogle Scholar
- Anisimova M, Nielsen R, Yang Z: Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 2003, 164: 1229-1236.PubMed CentralPubMedGoogle Scholar
- Posada D, Crandall KA: MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14: 817-818. 10.1093/bioinformatics/14.9.817View ArticlePubMedGoogle Scholar
- Swofford DL: PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Sunderland, Massachusetts: Sinauer Associates; 2002.Google Scholar
- Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24: 1596-1599. 10.1093/molbev/msm092View ArticlePubMedGoogle Scholar
- Larsen JE, Lund O, Nielsen M: Improved method for predicting linear B-cell epitopes. Immunome Res 2006, 2: 2. 10.1186/1745-7580-2-2PubMed CentralView ArticlePubMedGoogle Scholar
- Yang Z, Wong WS, Nielsen R: Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol 2005, 22: 1107-1118. 10.1093/molbev/msi097View ArticlePubMedGoogle Scholar
- Sun L, Liu WJ, Chen SJ, Shi HY, Liu XF: Influence of nonessential region on protective efficacy of recombinant fowlpox viruses. Acta Microbiologica Sinica 2005, 45: 359-362. (In Chinese)PubMedGoogle Scholar
- Liu WJ, Sun L, Chen SJ, Xu ZL, Liu JB, Liu XF: Construction and protective efficacies of two recombinant fowlpox viruses expressing the HA gene of H9 subtype AIV. Acta Veterinaria et Zootechnica Sinica 2008, 39: 327-332. (In Chinese)Google Scholar
- Ferreira L, Munoz-Barroso I, Marcos F, Shnyrov VL, Villar E: Sialidase, receptor-binding and fusion-promotion activities of Newcastle disease virus haemagglutinin-neuraminidase glycoprotein: a mutational and kinetic study. J Gen Virol 2004, 85: 1981-1988. 10.1099/vir.0.79877-0View ArticlePubMedGoogle Scholar
- Wong WS, Yang Z, Goldman N, Nielsen R: Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites. Genetics 2004, 168: 1041-1051. 10.1534/genetics.104.031153PubMed CentralView ArticlePubMedGoogle Scholar
- Suzuki Y, Gojobori T: A method for detecting positive selection at single amino acid sites. Mol Biol Evol 1999, 16: 1315-1328.View ArticlePubMedGoogle Scholar
- Biswas S, Akey JM: Genomic insights into positive selection. Trends Genet 2006, 22: 437-446. 10.1016/j.tig.2006.06.005View ArticlePubMedGoogle Scholar
- Iorio RM, Bratt MA: Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J Virol 1983, 48: 440-450.PubMed CentralPubMedGoogle Scholar
- Iorio RM, Borgman JB, Glickman RL, Bratt MA: Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Gen Virol 1986,67(Pt 7):1393-1403. 10.1099/0022-1317-67-7-1393View ArticlePubMedGoogle Scholar
- Cho SH, Kwon HJ, Kim TE, Kim JH, Yoo HS, Kim SJ: Variation of a newcastle disease virus hemagglutinin-neuraminidase linear epitope. J Clin Microbiol 2008, 46: 1541-1544. 10.1128/JCM.00187-08PubMed CentralView ArticlePubMedGoogle Scholar
- Hu S, Wang T, Liu Y, Meng C, Wang X, Wu Y, Liu X: Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 2010, 140: 92-97. 10.1016/j.vetmic.2009.07.029View ArticlePubMedGoogle Scholar
- Vigerust DJ, Shepherd VL: Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 2007, 15: 211-218. 10.1016/j.tim.2007.03.003View ArticlePubMedGoogle Scholar
- McGinnes LW, Wilde A, Morrison TG: Nucleotide sequence of the gene encoding the Newcastle disease virus hemagglutinin-neuraminidase protein and comparisons of paramyxovirus hemagglutinin-neuraminidase protein sequences. Virus Res 1987, 7: 187-202. 10.1016/0168-1702(87)90027-XView ArticlePubMedGoogle Scholar
- Miller PJ, Decanini EL, Afonso CL: Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infect Genet Evol 2010, 10: 26-35. 10.1016/j.meegid.2009.09.012View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.